GDR vs. LLAI, PRM, ABDX, IDHC, GENI, VRCI, POLX, RUA, IMM, and MXC
Should you be buying genedrive stock or one of its competitors? The main competitors of genedrive include LungLife AI (LLAI), Proteome Sciences (PRM), Abingdon Health (ABDX), Integrated Diagnostics (IDHC), GENinCode (GENI), Verici Dx (VRCI), Polarean Imaging (POLX), RUA Life Sciences (RUA), ImmuPharma (IMM), and Argent BioPharma (MXC). These companies are all part of the "medical" sector.
genedrive (LON:GDR) and LungLife AI (LON:LLAI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk.
genedrive has higher earnings, but lower revenue than LungLife AI. LungLife AI is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.
genedrive has a beta of 0.13, suggesting that its share price is 87% less volatile than the S&P 500. Comparatively, LungLife AI has a beta of -0.2, suggesting that its share price is 120% less volatile than the S&P 500.
genedrive received 242 more outperform votes than LungLife AI when rated by MarketBeat users.
1.2% of genedrive shares are owned by institutional investors. Comparatively, 42.2% of LungLife AI shares are owned by institutional investors. 38.4% of genedrive shares are owned by insiders. Comparatively, 48.7% of LungLife AI shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, genedrive had 1 more articles in the media than LungLife AI. MarketBeat recorded 1 mentions for genedrive and 0 mentions for LungLife AI. genedrive's average media sentiment score of 0.00 equaled LungLife AI'saverage media sentiment score.
LungLife AI's return on equity of -51.42% beat genedrive's return on equity.
Summary
genedrive beats LungLife AI on 7 of the 12 factors compared between the two stocks.
Get genedrive News Delivered to You Automatically
Sign up to receive the latest news and ratings for GDR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
genedrive Competitors List
Related Companies and Tools
